| For: | Zheng FY, Yang KS, Min WC, Li XZ, Xing Y, Wang S, Zhang YS, Zhao QC. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis. World J Gastrointest Surg 2024; 16(2): 571-584 [PMID: 38463352 DOI: 10.4240/wjgs.v16.i2.571] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v16/i2/571.htm |
| Number | Citing Articles |
| 1 |
Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi. Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds. BMJ Open Gastroenterology 2026; 13(1) doi: 10.1136/bmjgast-2026-002347
|
| 2 |
Katelin Durham, Tyler Atagozli, David E. Elliott, M. Nedim Ince. Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice. Biomedicines 2025; 13(2) doi: 10.3390/biomedicines13020491
|